Long Term Results of Interferon Treatment in Hairy Cell Leukemia Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL)

Giovanni Capnist(Ospedale San Bortolo), Eugenio Damask(Ospedale Policlinico San Martino), Teresa Lamparelli(Ospedale Policlinico San Martino), G. Pagnucco, L Resegotti, Teodoro Chisesi(Ospedale Civile di Venezia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Rosangela Invernizzi(University of Pavia), C. Guarnaccia(Ospedale Vincenzo Cervello), F Lauria, Giuseppe Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Pietro Leoni(Marche Polytechnic University), P Fabris, Massimo Federico(University of Modena and Reggio Emilia)
Leukemia & lymphoma/Leukemia and lymphoma
January 1, 1994
10.3109/10428199409049704
Cited by 12

Related Papers

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431